PL3489227T3 - Behenian rotygotyny, sposób jego wytwarzania i zastosowanie - Google Patents

Behenian rotygotyny, sposób jego wytwarzania i zastosowanie

Info

Publication number
PL3489227T3
PL3489227T3 PL16909205T PL16909205T PL3489227T3 PL 3489227 T3 PL3489227 T3 PL 3489227T3 PL 16909205 T PL16909205 T PL 16909205T PL 16909205 T PL16909205 T PL 16909205T PL 3489227 T3 PL3489227 T3 PL 3489227T3
Authority
PL
Poland
Prior art keywords
manufacturing
application
rotigotine behenate
rotigotine
behenate
Prior art date
Application number
PL16909205T
Other languages
English (en)
Inventor
Mina Yang
Yongtao JIANG
Ying MENG
Tao Wang
Qian qian XU
Xin SHAO
Chunjie SHA
Original Assignee
Shandong Luye Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Luye Pharmaceutical Co., Ltd. filed Critical Shandong Luye Pharmaceutical Co., Ltd.
Publication of PL3489227T3 publication Critical patent/PL3489227T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/08Hydrogen atoms or radicals containing only hydrogen and carbon atoms
    • C07D333/10Thiophene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
PL16909205T 2016-07-21 2016-07-21 Behenian rotygotyny, sposób jego wytwarzania i zastosowanie PL3489227T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2016/090803 WO2018014277A1 (zh) 2016-07-21 2016-07-21 罗替戈汀山嵛酸酯及其制备方法和用途
EP16909205.3A EP3489227B1 (en) 2016-07-21 2016-07-21 Rotigotine behenate, and manufacturing method and application thereof

Publications (1)

Publication Number Publication Date
PL3489227T3 true PL3489227T3 (pl) 2021-05-04

Family

ID=60992805

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16909205T PL3489227T3 (pl) 2016-07-21 2016-07-21 Behenian rotygotyny, sposób jego wytwarzania i zastosowanie

Country Status (15)

Country Link
US (2) US10669249B2 (pl)
EP (1) EP3489227B1 (pl)
JP (1) JP6751208B2 (pl)
KR (1) KR20190031314A (pl)
CN (1) CN109415335B (pl)
AU (1) AU2016415408B2 (pl)
BR (1) BR112019001035A2 (pl)
CA (1) CA3030043C (pl)
ES (1) ES2855976T3 (pl)
MY (1) MY195897A (pl)
PH (1) PH12018550212A1 (pl)
PL (1) PL3489227T3 (pl)
RU (1) RU2717542C9 (pl)
SG (1) SG11201811543XA (pl)
WO (1) WO2018014277A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2855976T3 (es) * 2016-07-21 2021-09-27 Shandong luye pharmaceutical co ltd Behenato de rotigotina y procedimiento de fabricación y aplicación del mismo
CN108341798B (zh) * 2017-01-23 2021-05-25 沈阳药科大学 罗替戈汀衍生物及其制备和应用
US20220340539A1 (en) * 2019-09-30 2022-10-27 Shandong Luye Pharmaceutical Co., Ltd. Compound and preparation method therefor and use thereof
AU2021368924B2 (en) * 2020-10-27 2024-07-11 Guangzhou Henovcom Bioscience Co., Ltd. Tetrahydronaphthalene compounds, pharmaceutical compositions, and uses thereof
WO2024208226A1 (zh) * 2023-04-04 2024-10-10 广州市恒诺康医药科技有限公司 四氢萘类化合物、其药物组合物及其用途
CN119504742B (zh) * 2024-11-18 2025-10-28 陕西师范大学 一种娃儿藤碱和安托芬的全合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE295726T1 (de) * 2002-12-02 2005-06-15 Sanol Arznei Schwarz Gmbh Verabreichung von rotigotine zur behandlung der parkinson'schen krankheit durch iontophorese
DE10361259A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von Rotigotine in einem Frühstadium von Morbus Parkinson zur Prävention des weiteren Neuronenverlustes
RU2589700C2 (ru) 2010-11-25 2016-07-10 Шан Донг Люие Фармацеутикал Ко., Лтд Композиции ротиготина, его производных, или фармацевтически приемлемых солей ротиготина или их производных
WO2013168033A1 (en) * 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for treatment of neurologic diseases
US9956201B2 (en) * 2014-07-21 2018-05-01 Spriaso Llc Compositions comprising bioreversible derivatives of hydroxy N-substituted-2-aminotetralins, and related dosage forms
WO2016014242A1 (en) * 2014-07-21 2016-01-28 Spriaso Llc Compositions comprising bioreversible derivatives of hydroxy n-substituted-2-aminotetralins, dosage forms, and related methods
ES2855976T3 (es) * 2016-07-21 2021-09-27 Shandong luye pharmaceutical co ltd Behenato de rotigotina y procedimiento de fabricación y aplicación del mismo

Also Published As

Publication number Publication date
RU2717542C1 (ru) 2020-03-24
US20200255396A1 (en) 2020-08-13
CA3030043C (en) 2021-01-19
EP3489227B1 (en) 2020-10-21
BR112019001035A2 (pt) 2019-04-30
CA3030043A1 (en) 2018-01-25
US11111227B2 (en) 2021-09-07
ES2855976T3 (es) 2021-09-27
SG11201811543XA (en) 2019-02-27
US20190330177A1 (en) 2019-10-31
KR20190031314A (ko) 2019-03-25
PH12018550212A1 (en) 2019-10-28
CN109415335A (zh) 2019-03-01
JP6751208B2 (ja) 2020-09-02
EP3489227A4 (en) 2020-01-22
JP2019523297A (ja) 2019-08-22
RU2717542C9 (ru) 2020-08-12
MY195897A (en) 2023-02-27
AU2016415408B2 (en) 2019-04-11
WO2018014277A1 (zh) 2018-01-25
AU2016415408A1 (en) 2019-01-17
CN109415335B (zh) 2020-06-05
EP3489227A1 (en) 2019-05-29
US10669249B2 (en) 2020-06-02

Similar Documents

Publication Publication Date Title
HUE038439T2 (hu) Nyomásszabályozó eszköz, nevezett nyomásszabályozó eszközt tartalmazó adagoló és elkészítési eljárás
SG11201703106PA (en) Device, method, and program
GB201403039D0 (en) Encoder, decoder and method
GB201411531D0 (en) Encoder, decoder and method
EP3300392A4 (en) Information-processing device, information-processing method, and program
EP3333283A4 (en) Sliding member and manufacturing method therefor
GB2557741B (en) Icariside compound, preperation method thereof, and application thereof
SG11201800116XA (en) Room-temperature curable inorganic coating and manufacturing method thereof
ZA201705927B (en) Wrapped object, mandrel therefor and method
PT3461308T (pt) Sistemas e métodos de transferência de um dispositivo sem fios
EP3287228A4 (en) Assembly manufacturing device and assembly manufacturing method
EP3229514A4 (en) Wireless resource sharing method and device
PL3064542T3 (pl) Biodegradowalna termoplastyczna kompozycja polimerowa, sposób jej wytwarzania oraz zastosowanie
EP3323599A4 (en) Forming device and forming method
GB201805095D0 (en) Compostion, method and use
EP3300832A4 (en) Metrhod for manufacturing microneedle and device for manufacturing microneedle
GB201608192D0 (en) Method, array and use thereof
GB201516801D0 (en) Method, array and use thereof
EP3205418A4 (en) Material-property-value estimating method, material-property-value estimating device, and steel-strip manufacturing method
GB201403038D0 (en) Encoder, decoder and method
EP3358480A4 (en) Drawing creation device and drawing creation method
EP3307211A4 (en) A close-cell structured stent, a preparation method and use thereof
EP3275494A4 (en) Information-processing device, information-processing method, and program
GB201406197D0 (en) Polymeric rule die, and formulation therefor
PL3489227T3 (pl) Behenian rotygotyny, sposób jego wytwarzania i zastosowanie